The Next Era of Surgical Robotics: Market Fragmentation, Strategic Signals, and IP Leadership

The Next Era of Surgical Robotics: Market Fragmentation, Strategic Signals, and IP Leadership

Published Date: 07.10.2025

In a $188B market where fewer than 6% of surgeries use robots, the field is no longer dominated by a single system. Instead, a new wave of highly specialized, capital-backed platforms is emerging, each targeting different procedures, care settings, and deployment strategies.

The latest PatentVest Pulse report offers the most comprehensive strategic view to date into the technologies, companies, and IP positions shaping the future of robotic surgery.

Inside the analysis:

• Company-Level Benchmarking of 29 emerging players, including CMR Surgical, THINK Surgical, Distalmotion, Neocis, Microbot Medical, EndoQuest Robotics, Vicarious Surgical, Stereotaxis, and more, evaluating platform design, clinical validation, regulatory pathways, and commercialization models.
• IP Landscape Mapping of over 18,000 patent families across 2,000+ organizations, revealing who owns the core innovations and where untapped white space remains. In surgical robotics, IP is no longer a back-office concern; it is the foundation for defensibility, market access, and long-term differentiation.

READ FULL REPORT

MDB Capital is a wholly-owned subsidiary of MDB Capital Holdings (Nasdaq: MDBH) and a broker-dealer registered with the U.S. Securities and Exchange Commission, a member of FINRA and a member of SIPC. Securities trading, account management, and investment banking services are offered by MDB Capital.

PatentVest, Inc. is a wholly owned subsidiary of MDB Capital Holdings and an affiliated company of MDB Capital.

All patent portfolio data and analysis in this report are based on publicly available information as of June 2025, sourced through PatentVest, our proprietary global patent database. While every effort has been made to ensure accuracy and completeness, the findings may not reflect unpublished, pending, or confidential filings. Companies may hold additional IP assets that are not yet publicly disclosed. This report should be considered a snapshot, not a definitive account, of current IP positions.

Information in this message from employees of MDB Capital or an affiliated company is based upon information that is believed to be reliable. However, neither MDB Capital nor its affiliates warrant its completeness, accuracy or adequacy.